rs186232930

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001001344.3(ATP2B3):​c.-3A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00019 in 1,187,770 control chromosomes in the GnomAD database, including 1 homozygotes. There are 75 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).

Frequency

Genomes: 𝑓 0.00088 ( 0 hom., 31 hem., cov: 25)
Exomes 𝑓: 0.00012 ( 1 hom. 44 hem. )

Consequence

ATP2B3
NM_001001344.3 5_prime_UTR

Scores

2

Clinical Significance

Likely benign no assertion criteria provided B:1

Conservation

PhyloP100: 0.836

Publications

0 publications found
Variant links:
Genes affected
ATP2B3 (HGNC:816): (ATPase plasma membrane Ca2+ transporting 3) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 3. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ATP2B3 Gene-Disease associations (from GenCC):
  • X-linked progressive cerebellar ataxia
    Inheritance: XL, Unknown Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • X-linked non progressive cerebellar ataxia
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant X-153536245-A-G is Benign according to our data. Variant chrX-153536245-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 3042913.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000882 (100/113322) while in subpopulation AFR AF = 0.00303 (95/31319). AF 95% confidence interval is 0.00254. There are 0 homozygotes in GnomAd4. There are 31 alleles in the male GnomAd4 subpopulation. Median coverage is 25. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 31 XL,Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001001344.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP2B3
NM_001001344.3
MANE Select
c.-3A>G
5_prime_UTR
Exon 3 of 22NP_001001344.1Q16720-1
ATP2B3
NM_001388362.1
c.-3A>G
5_prime_UTR
Exon 3 of 22NP_001375291.1
ATP2B3
NM_001388361.1
c.-3A>G
5_prime_UTR
Exon 2 of 21NP_001375290.1Q16720-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP2B3
ENST00000263519.5
TSL:1 MANE Select
c.-3A>G
5_prime_UTR
Exon 3 of 22ENSP00000263519.4Q16720-1
ATP2B3
ENST00000359149.9
TSL:1
c.-3A>G
5_prime_UTR
Exon 3 of 23ENSP00000352062.3Q16720-2
ATP2B3
ENST00000496610.2
TSL:3
c.-3A>G
5_prime_UTR
Exon 3 of 23ENSP00000516173.1A0A994J5M1

Frequencies

GnomAD3 genomes
AF:
0.000856
AC:
97
AN:
113272
Hom.:
0
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.00294
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000185
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00417
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00131
GnomAD2 exomes
AF:
0.000252
AC:
35
AN:
139019
AF XY:
0.000277
show subpopulations
Gnomad AFR exome
AF:
0.00313
Gnomad AMR exome
AF:
0.0000863
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000351
Gnomad OTH exome
AF:
0.000271
GnomAD4 exome
AF:
0.000117
AC:
126
AN:
1074448
Hom.:
1
Cov.:
31
AF XY:
0.000126
AC XY:
44
AN XY:
350394
show subpopulations
African (AFR)
AF:
0.00328
AC:
85
AN:
25889
American (AMR)
AF:
0.0000942
AC:
3
AN:
31854
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18857
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28764
South Asian (SAS)
AF:
0.00
AC:
0
AN:
51099
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38428
Middle Eastern (MID)
AF:
0.000729
AC:
3
AN:
4113
European-Non Finnish (NFE)
AF:
0.0000289
AC:
24
AN:
830257
Other (OTH)
AF:
0.000243
AC:
11
AN:
45187
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000882
AC:
100
AN:
113322
Hom.:
0
Cov.:
25
AF XY:
0.000874
AC XY:
31
AN XY:
35462
show subpopulations
African (AFR)
AF:
0.00303
AC:
95
AN:
31319
American (AMR)
AF:
0.000185
AC:
2
AN:
10811
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2655
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3580
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2788
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6324
Middle Eastern (MID)
AF:
0.00457
AC:
1
AN:
219
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53390
Other (OTH)
AF:
0.00129
AC:
2
AN:
1550
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000434
Hom.:
2
Bravo
AF:
0.000986

ClinVar

ClinVar submissions as Germline
Significance:Likely benign
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
ATP2B3-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
12
DANN
Benign
0.69
PhyloP100
0.84
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs186232930; hg19: chrX-152801703; API